GlassScriptPhysician profile
Steven A Siciliano
NPI 1942247655
$2,092.81
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $758 · 2020: $431 · 2021: $324 · 2022: $220 · 2023: $321 · 2024: $39.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $922.12 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $517.79 | 2019-2021 | |
| Abbvie INC. | $98.79 | 2020-2021 | |
| Davol INC. | $91.03 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $87.92 | 2021 | |
| Sun Pharmaceutical Industries INC. | $56.55 | 2019-2023 | Odomzo, Blu-U |
| Boston Scientific Corporation | $41.22 | 2023 | |
| Organogenesis INC. | $37.08 | 2023 | Puraply |
| Tela Bio, INC. | $34.73 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sandoz INC. | $27.05 | 2023 | Hyrimoz |
| Dusa Pharmaceuticals, INC. | $25.66 | 2019 | |
| Aclaris Therapeutics, INC. | $19.82 | 2019 | |
| Vyne Pharmaceuticals INC. | $18.82 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $18.23 | 2019 | |
| Sientra, INC. | $15.18 | 2020-2023 | Sientra High Strength Cohesive Silicone Gel Breast Implant |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $14.48 | 2022 | |
| Lilly USA, LLC | $13.83 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.66 | 2020 | |
| Galderma Laboratories, L.P. | $13.57 | 2021 | |
| Mylan Pharmaceuticals INC. | $13.44 | 2019 | |
| Baudax Bio INC. | $11.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Siciliano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.